Stock Price
367.80
Daily Change
-5.30 -1.42%
Monthly
6.07%
Yearly
-37.93%
Q1 Forecast
351.07

Novo Nordisk reported DKK181.88B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Bausch Health Companies USD 6.25B 265M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novo Nordisk DKK 181.88B 19.18B Sep/2025
Novo Nordisk DKK 25.71B 148.69B Jun/2025
Pacira USD 562.75M 182.86M Sep/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025